Factors Affecting Survival Rates Among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia

References

• Bruchfeld J, Correia-neves M, Ka¨llenius G. Tuberculosis and HIV Coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871. doi:10.1101/cshperspect.a01787125722472
   PubMed Web of Science ®Google Scholar
• Deribew A, Tesfaye M, Hailmichael Y, et al. Common mental disorders in TB/HIV co-infected patients in Ethiopia. BMC Infect. Dis. 2010;10(1):1–8. doi:10.1186/1471-2334-10-20120044936
   PubMedGoogle Scholar
• Deribew A, HaileMichael Y, Tesfaye M, et al. The synergy between TB and HIV co-infection on perceived stigma in Ethiopia. BMC Res Notes. 2010;3:2–5. doi: 10.1186/1756-0500-3-249.20044943
   PubMedGoogle Scholar
• UNAIDS. Global AIDS Monitoring; 2016 Available from https://www.aidsdatahub.org/global-aids-monitoring-2017-indicators-monitoring-2016-united-nations-political-declaration-hiv-and. Accessed on January 22, 2018.
   Google Scholar
• WHO. Global Tuberculosis Report; 2018 Available from https://apps.who.int/iris/handle/10665/274453. Accessed on October 10, 2019.
   Google Scholar
• WHO. HIV-Associated Tuberculosis, Achievements in 2017; 2018 Available from http://www.who.int/tb/areas-of-work/tb-hiv/tbhiv_factsheet.pdf?ua=1. Accessed on January 5, 2019.
   Google Scholar
• EPHI, WHO, FMOH of Ethiopia: Service Availability and Readiness Assessment 2016: Summary Report; 2016 Available from https://www.washinhcf.org/wp-content/uploads/2017/03/Final-SARA-Report-Jan-2017.pdf; Accessed on January 8, 2018
   Google Scholar
• Gebremariam MK, Bjune GA, Frich JC. Lay beliefs of TB and TB/HIV co-infection in Addis Ababa, Ethiopia: a qualitative study. BMC Res Notes. 2011;4(1):2–6. doi:10.1186/1756-0500-4-27721208422
   PubMedGoogle Scholar
• Deribew A, Abebe G, Apers L, et al. Prejudice and misconceptions about tuberculosis and HIV in rural and urban communities in Ethiopia: a challenge for the TB/HIV control program. BMC Public Health. 2010;10(1):1–10. doi:10.1186/1471-2458-10-40020043862
   PubMedGoogle Scholar
• Gesesew H, Tsehaineh B, Massa D, Tesfay A, Kahsay H, Mwanri L. The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort. Infect Dis Poverty. 2016;5:1–10.26796785
   PubMedGoogle Scholar
• Gesesew H, Tsehayneh B, Massa D, Gebremedhin A, Kahsay H, Mwanri L. Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia. Infect Dis Poverty. 2016;5:1–9. doi:10.1186/s40249-016-0099-826796785
   PubMedGoogle Scholar
• Sileshi B, Deyessa N, Girma B, Melese M, Suarez P. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study. BMC Infect. Dis. 2013;13(1):1–10. doi:10.1186/1471-2334-13-29723280237
   PubMedGoogle Scholar
• Chow S, Shao JWH. Sample Size Calculations in Clinical Research; 2008 Available from http://powerandsamplesize.com/Calculators/Test-Time-To-Event-Data/Cox-PH-2-Sided-Equality. Accessed on May 1, 2018.
   Google Scholar
• WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommended for a Public Health Approach; 2016 Available from https://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed on July 20, 2018.
   Google Scholar
• Otavio R, Velasque L, Ribeiro SR, et al. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death. BMC Infect Dis. 2017;17:1–10. doi:10.1186/s12879-016-2122-x28049444
   PubMedGoogle Scholar
• Camara A, Sow MS, Toure A, et al. Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry. Epidemiol Public Heal. 2017:1–8. doi:10.1016/j.respe.2017.05.011.
   Google Scholar
• WHO. Global Tuberculosis Report; 2017 Available from https://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf?ua=1. Accessed on January 8, 2018.
   Google Scholar
• Ismail I, Bulgiba A. Predictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia. PLoS One. 2013;8(8):1–7. doi:10.1371/journal.pone.0073250
   Google Scholar
• Aluoch JA. Tuberculosis/HIV Co-infection. East Afr Med J. 2013;89:68–74.
   Google Scholar
• Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis: clinical update. Clin. Infect. Dis. 2010;50(10):1377–1386. doi:10.1086/65214720388036
   PubMedGoogle Scholar
• Worodria W, Massinga-Loembe M, Mazakpwe D, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr. 2011;58:32–37. doi:10.1097/QAI.0b013e3182255dc221654499
   PubMed Web of Science ®Google Scholar
• Bigna JJR, Noubiap JJN, Agbor AA, et al. Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the yaoundé central hospital, cameroon: an 8-year retrospective cohort study (2006–2013). PLoS One. 2015:1–13. doi:10.1371/journal.pone.0132394.
   Google Scholar
• UNAIDS. Global AIDS Update, Ending AIDS, Progress Towards the 90- 90-90 targets; 2017 Available from https://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017. Acceessd on February 6, 2018.
   Google Scholar
• Nunn AJ, Mwaba P, Chintu C, et al. Role of co-trimoxazole prophylaxis in reducing mortality randomised clinical trial. BMJ. 2008;337(jul10 1):2–8. doi:10.1136/bmj.a257
   Google Scholar
• Hasse B, Walker AS, Fehr J, et al. Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the swiss HIV cohort study. Antimicrob. Agents Chemother. 2014;58(4):2363–2368. doi:10.1128/AAC.01868-1324514096
   PubMedGoogle Scholar
• Hailu R, Eshetu W. Survival of HIV-TB co-infected adult patients under ART in ambo referral hospital, Ethiopia. Ethiop J Heal Dev. 2013;27:88–93.
   Web of Science ®Google Scholar
• Gesesew H, Tsehaineh B, Massa D, et al. The role of social determinants on tuberculosis/HIV co ‑ infection mortality in southwest Ethiopia: a retrospective cohort study. BMC Res Notes. 2016;9(1):4–11. doi:10.1186/s13104-016-1905-x26724805
   PubMedGoogle Scholar
• Sullivan ZA, Wong EB, Ndung T, Kasprowicz VO, Bishai WR. Latent and active tuberculosis infection increase immune activation in individuals co-infected with HIV. EBioMedicine. 2015;2(4):334–340. doi:10.1016/j.ebiom.2015.03.00526114158
   PubMedGoogle Scholar
• PEPFAR Ethiopia. Ethiopia Country/Regional Operational Plan (COP/ROP) 2017 Strategic Direction Summary; 2017 Available from https://copsdata.amfar.org/SDS/2017/Ethiopia.pdf. Accessed on April 21, 2020.
   Google Scholar
• Erdaw T, Ameni G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health. 2016;38:1–10.
   Google Scholar
• Yimer YT, Yalew AW. Magnitude and predictors of Anti-Retroviral Treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia. PLoS One. 2015;10(5).
   PubMedGoogle Scholar